Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
US7566699B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2004 |
| Grant date | Jul 28, 2009 |
| Priority date | — |
| Expiry date | Jun 3, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides fused heterocyclic derivatives represented by the general formula:wherein R1 represents H, halogen, OH, etc.; R2 represents H, halogen or an alkyl group; R3 and R4 represent H, OH, halogen, etc.; Q represents alkylene, etc.; ring A represents aryl or heteroaryl; and G representsor pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.